Common deleted genes in the 5q-syndrome: thrombocytopenia and reduced erythroid colony formation in SPARC null mice

被引:53
作者
Lehmann, S. [1 ]
O'Kelly, J.
Raynaud, S.
Funk, S. E.
Sage, E. H.
Koeffler, H. P.
机构
[1] Karolinska Univ Hosp, Dept Hematol, S-14186 Stockholm, Sweden
[2] Univ Calif Los Angeles, Sch Med, Cedars Sinai Med Ctr, Div Hematol Oncol, Los Angeles, CA USA
[3] Karolinska Univ Hosp, Dept Hematol, Stockholm, Sweden
[4] Hop Archet, Dept Hematol Biol, Nice, France
[5] Benaroya Inst Virginia Mason, Hope Heart Program, Seattle, WA USA
关键词
myelodysplastic syndrome; 5q-syndrome; SPARC;
D O I
10.1038/sj.leu.2404852
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The commonly deleted region ( CDR) for the 5q - syndrome has been identified as a 1.5- megabase interval on human chromosome 5q32. We studied, by real- time reverse- transcription ( RT) PCR, the expression of 33 genes within the CDR that are known to be expressed in CD34 hematopoietic stem cells. Genes in the 5q - samples that showed the most pronounced decrease in expression compared to non- 5q - samples were: solute carrier family 36, member 1 ( SLC36A1; 89% downregulated), RasGTPase- activating protein SH3 domain- binding ( G3BP; 79%), antioxidant protein 1 ( ATOX1; 76%), colony- stimulating factor- 1 receptor precursor ( CSF1R; 76%), ribosomal protein S14 ( RPS14; 74%), platelet- derived growth factor receptor- b ( PDGFRB; 73%), Nef- associated factor 1 ( TNIP1; 72%), secreted protein, acidic and rich in cysteine ( SPARC; 71%), annexin VI ( ANAX6; 69%), NSDT ( 66%) and TIGD ( 60%). We further studied the hematopoietic system in SPARC- null mice. These mice showed significantly lower platelet counts compared to wildtype animals ( P 0.008). Although hemoglobin, hematocrit and mean corpuscular volume ( MCV) were lower in mice lacking SPARC, differences were not statistically significant. SPARCnull mice showed a significantly impaired ability to form erythroid burst- forming units ( BFU- E). However, no significant differences were found in the formation of erythroid colonyforming units ( CFU- E), granulocyte/ monocyte colony- forming units ( CFU- GM) or megakaryocyte colony- forming units ( CFUMk) in these animals. We conclude that many of the genes within the CDR associated with the 5q - syndrome exhibit significantly decreased expression and that SPARC, as a potential tumor suppressor gene, may play a role in the pathogenesis of this disease.
引用
收藏
页码:1931 / 1936
页数:6
相关论文
共 32 条
[1]  
BOULTWOOD J, 1994, BLOOD, V84, P3253
[2]   Narrowing and genomic annotation of the commonly deleted region of the 5q-syndrome [J].
Boultwood, J ;
Fidler, C ;
Strickson, AJ ;
Watkins, F ;
Gama, S ;
Kearney, L ;
Tosi, S ;
Kasprzyk, A ;
Cheng, JF ;
Jaju, RJ ;
Wainscoat, JS .
BLOOD, 2002, 99 (12) :4638-4641
[3]   Primary mesenchymal cells isolated from SPARC-null mice exhibit altered morphology and rates of proliferation [J].
Bradshaw, AD ;
Francki, A ;
Motamed, K ;
Howe, C ;
Sage, EH .
MOLECULAR BIOLOGY OF THE CELL, 1999, 10 (05) :1569-1579
[4]   SPARC-null mice exhibit increased adiposity without significant differences in overall body weight [J].
Bradshaw, AD ;
Graves, DC ;
Motamed, K ;
Sage, EH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (10) :6045-6050
[5]   SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury [J].
Bradshaw, AD ;
Sage, EH .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (09) :1049-1054
[6]   Myelodysplasic syndromes: A comprehensive review [J].
Catenacci, DVT ;
Schiller, GJ .
BLOOD REVIEWS, 2005, 19 (06) :301-319
[7]  
CHUI DHK, 1978, BLOOD, V51, P539
[8]   COMPLEX-FORMATION OF HUMAN THROMBOSPONDIN WITH OSTEONECTIN [J].
CLEZARDIN, P ;
MALAVAL, L ;
EHRENSPERGER, AS ;
DELMAS, PD ;
DECHAVANNE, M ;
MCGREGOR, JL .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1988, 175 (02) :275-284
[9]  
CLEZARDIN P, 1991, J BONE MINER RES, V6, P1059
[10]   Doxycycline-inducible expression of SPARC/osteonectin/BM40 in MDA-MB-231 human breast cancer cells results in growth inhibition [J].
Dhanesuan, N ;
Sharp, JA ;
Blick, T ;
Price, JT ;
Thompson, EW .
BREAST CANCER RESEARCH AND TREATMENT, 2002, 75 (01) :73-85